|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Systemic cytokine response in patients with community-acquired pneumonia 显示文摘 | Endeman H Meijvis SC Rijkers GT | 2011 | Eur Respir2011，37，6： | 1 |
| 2 | Dexamethasone and length of hospital stay in patients with community - acquired pneumonia: a randomized, double - blind, placebo - controlled trial显示文摘 | Meijvis S Hardeman H Remmelts H | 2011 | Lancet2011，377，9782： | 1 |
| 3 | Dexamethasone downregulates the systemic cytokine response in patients with community-acquired pneumonia显示文摘 | Remmelts HI-I Meijvis SC Biesma DH van Velzen-Blad H Voorn GP Grutters JC | 2012 | Clin Vaccine Immunol2012，19，9： | 1 |
| 4 | Man- nose-binding lectin (MBL2) and ficolin 2 (FCN2) polymorphisms in patients on peritoneal dialysis with staphylococcal peritonitis显示文摘 | Meijvis SC Herpers BL Endeman H | 2011 | Nephrol Dial Transplant2011，26，3： | 1 |
| 5 | Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial显示文摘 | Meijvis SC Hardeman H Remmelts HH | 2011 | Lancet2011，377，9782： | 1 |
| 6 | Dexamethasone and length of hospital stay in patients with community-acquiredpneumonia: a randomised, double-blind, placebo-controlled trial 显示文摘 | Meijvis SC Hardeman H Remmehs HH | 2011 | Lancet2011，377，9782： | 1 |
| 7 | The effect of age on the systemic inflammatory response in patients with community- acquired pneumonia 显示文摘 | Vught LA Endeman H Meijvis SC | 2014 | Clin Microbiol Infect2014，20，11： | 1 |
| 8 | Dexamethasone downregu- lates the systemic cytokine response in patients with community-ac- quired pneumonia 显示文摘 | Remmelts HH Meijvis SC Biesma DI't | 2012 | Clin Vaccine Immunol2012，19，9： | 1 |
| 9 | Dexamethasone treatment has no effect on the formation of pneumococcal antibodies during com- munity-acquired pneumonia显示文摘 | van Mens SP Meijvis SC Grutters JC | 2012 | Clin Vaccine Immuno12012，19，5： | 1 |
| 10 | Dexamethasone and length of hospital stay in patients with community-acquired pneumonia : a randomised, double-blind, placebo-controlled trial 显示文摘 | Meijvis SC Hardeman H Remmelts HH | 2011 | Lancet2011，377，9782： | 1 |
| 11 | Systemic cytokine response in patients with communlty-acquired pneumonia 显示文摘 | Endeman H Meijvis SC Rijkers GT | 2011 | Eur Respir J2011，37，6： | 1 |
| 12 | Systemic cytokine re- sponse in patients with community acquired pneumonia 显示文摘 | Endeman H Meijvis SC Rijkers GT | 2011 | Eur Respir J2011，37，6： | 1 |
| 13 | Dexamethasone andlength of hospital stay in patients with community-acquired pneumonia:a randomised,double-blind,placebo-controlled trial显示文摘 | Meijvis SC Hardeman H Remmelts HH | 2011 | The Lancet2011，377，： | 1 |
| 14 | Dexamethasone downregulates the systemic cytokine response in patients with com- munity-acquired pneumonia 显示文摘 | Remmelts HH Meijvis SC Biesma DH | 2012 | Clin Vaccine Immunol2012，19，9： | 1 |
| 15 | Prognostic value of serum angiotensin-coverting enzyme activity for outcome of community-acquired pneumonia显示文摘 | Meijvis SC Cornips MC Endeman H | 2011 | Clin Chem Lab Med2011，49，9： | 1 |
| 16 | Biomarkers define the clinical response to dexamethasone in community acquired pneumonia显示文摘 | Remmelts HH Meijvis SC Heijligenberg R | 2012 | J Infect2012，65，1： | 1 |
| 17 | Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial 显示文摘 | Meijvis SC Hardeman H Remmelts HH | 2011 | Lancet2011，377，9782： | 1 |
| 18 | Dexamethasoneand length of hospital stay in patients with community- ac-quired pneumonia: a randomized, double-blind, placebo-controlled trial 显示文摘 | Meijvis S Hardeman H Remmelts H | 2011 | Lancet2011，377，： | 1 |
| 19 | Dexamethasone downregulates the systemic cytokine response in patients with communityacquired root显示文摘 | Remmelts HH Meijvis SC Biesma DH | 2012 | Clin Vaccine Immunol2012，12，9： | 1 |
| 20 | The effect of age on the systemic inflammatory response in patients with community-acquired pneumonia显示文摘 | Vught LA Endeman H Meijvis SC | 2014 | Clin Microbiol Infect2014，14，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员